Transmembrane proteins act as an intermediary for a broad range of biological process. Making up 20% to 30% the proteome, their ubiquitous nature has resulted in them comprising 50% all targets drug design. Despite importance, they make only 4% structures PDB database, primarily owing difficulties associated with isolating and characterizing them. Membrane protein docking algorithms could help ...